These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34554230)

  • 1. Comment on: Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series.
    Mungmunpuntipantip R; Wiwanitkit V
    Rheumatology (Oxford); 2021 Dec; 61(1):e29. PubMed ID: 34554230
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series: reply.
    Furer V; Zisman D; Elkayam O
    Rheumatology (Oxford); 2021 Dec; 61(1):e30. PubMed ID: 34554242
    [No Abstract]   [Full Text] [Related]  

  • 3. Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series.
    Furer V; Zisman D; Kibari A; Rimar D; Paran Y; Elkayam O
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI90-SI95. PubMed ID: 33848321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient.
    Maruki T; Ishikane M; Suzuki T; Ujiie M; Katano H; Ohmagari N
    Int J Infect Dis; 2021 Dec; 113():55-57. PubMed ID: 34587536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes zoster viral infection after AZD1222 and BNT162b2 coronavirus disease 2019 mRNA vaccines: a case series.
    Koumaki D; Krueger-Krasagakis SE; Papadakis M; Katoulis A; Koumaki V; Evangelou G; Stefanidou M; Mylonakis D; Zografaki K; Krasagakis K
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):e85-e86. PubMed ID: 34606142
    [No Abstract]   [Full Text] [Related]  

  • 6. Ipsilateral herpes zoster after the first dose of BNT162b2 mRNA COVID-19 vaccine.
    Tessas I; Kluger N
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e620-e622. PubMed ID: 34058038
    [No Abstract]   [Full Text] [Related]  

  • 7. Varicella-Zoster Virus (VZV) Meningitis in an Immunocompetent Adult after BNT162b2 mRNA COVID-19 Vaccination: A Case Report.
    Medhat R; El Lababidi R; Abdelsalam M; Nusair A
    Int J Infect Dis; 2022 Jun; 119():184-186. PubMed ID: 35398296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases.
    Fornaro M; Venerito V; Iannone F; Cacciapaglia F
    J Rheumatol; 2022 Mar; 49(3):334-335. PubMed ID: 35033998
    [No Abstract]   [Full Text] [Related]  

  • 9. Association study between herpes zoster reporting and mRNA COVID-19 vaccines (BNT162b2 and mRNA-1273).
    Préta LH; Contejean A; Salvo F; Treluyer JM; Charlier C; Chouchana L
    Br J Clin Pharmacol; 2022 Jul; 88(7):3529-3534. PubMed ID: 35174524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].
    Matsumura A; Katsuki K; Akimoto M; Sakuma T; Nakajima Y; Miyazaki T; Fujisawa S; Nakajima H
    Rinsho Ketsueki; 2021; 62(11):1639-1642. PubMed ID: 34866090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and BNT162b2 mRNA COVID-19 vaccination.
    Joob B; Wiwanitkit V
    Acta Biomed; 2022 Jan; 92(6):e2021485. PubMed ID: 35075060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated herpes zoster in an immune-competent patient after SARS-CoV-2 vaccine (BNT162b2 Comirnaty, Pfizer).
    Zengarini C; Misciali C; Ferrari T; Dika E; La Placa M; Piraccini BM; Baraldi C
    J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):e622-e623. PubMed ID: 35429051
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-episodic angioedema with eosinophilia after BNT162b2 mRNA COVID-19 vaccination.
    Ishizuka K; Katayama K; Kaji Y; Tawara J; Ohira Y
    QJM; 2021 Dec; 114(10):745-746. PubMed ID: 34546346
    [No Abstract]   [Full Text] [Related]  

  • 14. Herpes Zoster Following a Nucleoside-Modified Messenger RNA COVID-19 Vaccine.
    Dezoteux F; Massip É; Marcant P; Sobaszek A; Chopin MC; Vuotto F; Staumont-Sallé D
    Cutis; 2022 Jan; 109(1):E5-E7. PubMed ID: 35180059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia.
    Herishanu Y; Avivi I; Levi S; Shefer G; Bronstein Y; Moshiashvili MM; Ziv T; Scarfò L; Perry C; Ghia P
    Blood Adv; 2022 Jan; 6(1):148-151. PubMed ID: 34614513
    [No Abstract]   [Full Text] [Related]  

  • 16. Herpes zoster infection following SARS-CoV-2 vaccine BNT162b2.
    Lauro W; Cillo F; Nastro F; Fabbrocini G; Marasca C
    Ital J Dermatol Venerol; 2023 Aug; 158(4):364-365. PubMed ID: 37539506
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.
    Lui DTW; Lee KK; Lee CH; Lee ACH; Hung IFN; Tan KCB
    Front Public Health; 2021; 9():778964. PubMed ID: 34888290
    [No Abstract]   [Full Text] [Related]  

  • 18. Herpes zoster and alopecia areata following mRNA BNT162b2 COVID-19 vaccine: Controversial immune effects.
    Martora F; Fornaro L; Picone V; Marasca D; Gargiulo M; Annunziata MC; Fabbrocini G; Marasca C
    J Cosmet Dermatol; 2023 Jan; 22(1):36-38. PubMed ID: 36239007
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrence of Varicella-Zoster Virus Keratitis After SARS-CoV-2 Vaccination.
    Ryu KJ; Kim DH
    Cornea; 2022 May; 41(5):649-650. PubMed ID: 35383620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months.
    Ponticelli D; Antonazzo IC; Caci G; Vitale A; Della Ragione G; Romano ML; Borrelli M; Schiavone B; Polosa R; Ferrara P
    J Travel Med; 2021 Dec; 28(8):. PubMed ID: 34697627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.